Perspective Therapeutics, Inc.
PublicPerspective Therapeutics, Inc. is now publicly traded
The data on this page reflects Perspective Therapeutics, Inc.'s private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Last Round
Follow-on Offering
Jan 22, 2024
Total Funding Raised
$20.85M
Company Overview
Perspective Therapeutics, Inc. is a radiopharmaceutical development company that develops and commercializes precision targeted alpha therapies to treat cancer.
AI Layer
Non-AI
Keywords
Perspective Therapeutics, Inc. Comparables
Compare Perspective Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Boomray Pharmaceuticals Co., Ltd. | 66% | |
| Skopos Bio | 57% | |
| Hangzhou Eli Radiopharma Co., Ltd. | 53% |
Perspective Therapeutics, Inc. Funding Rounds
Historical fundraising activity
Key People
Founding team and executive leadership
Perspective Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Lantheus Alpha Therapy, LLC | Follow-on Offering |
Perspective Therapeutics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access